Resistell technology featured in "Die Zeit" magazine

As medical developments zoom ahead, it’s increasingly the startups that are leading the charge. From young teams springing out of Europe’s best medical universities, to entrepreneurs twinning up with expert clinical practitioners who have found a problem to solve, there is no shortage of European medtech startups that are revolutionizing healthcare.

Meet the 5 Swiss startups which took the top spots in the as newcomers in this year's ranking. Each year 100 investors and experts choose their ten favourite young companies with the most promising business idea. The result is the TOP 100 Swiss Startup ranking.

Resistell - The EPFL spin-off knows how to find the right medication around 100 times faster. This can significantly increase a patient's chance of survival.

In their development, start-ups face an important challenge: the creation of a prototype. A crucial step, where many risks have to be overcome and where different skills have to be combined.

Swiss Biotech startups are considered among the most promising and innovative companies in the world. Big industry players have already acquired many Biotech startups and large transactions had a relevant impact on the entire Swiss ecosystem. Discover now 10 Swiss Biotech startups to watch in 2020. The practice of medicine has changed dramatically over the past years and we all know that the healthcare systems are becoming more complex and more expensive. Much of that progress is likely to result from advances in personalized medicine. This new treatment paradigm aims to ensure that patients get the therapies best suited to their specific genetic conditions.

Resistell AG has today closed an oversubscribed series A financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s fastest phenotypic antibiotic susceptibility test.

The future of antibiotics depends on all of us! Each November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.

Despite the fact that the spread of resistant bacteria is seen as one of the biggest global threats, pharmaceutical companies are pulling out of research into new antibiotics.

For the first time Resistell with its Rapid AST made it to TOP100 this year! We are super proud and have big ambitions to climb up the list! Stay tuned!

Join us in Zurich at the Annual Meeting of Swiss Society for Microbiology and learn more about our rapid AST solution. We invite you to our booth number 24. See you soon!

In the immensity of the cosmos, could life develop on another planet than Earth? Nano-motion device invented be Sandor Kasas and Giovanni Dietler from EPFL Lausanne...

Thank you for giving us the opportunity to take part in the Pitch Night Boston 2019: The Future of HealthTech and to present our rapid AST.

Join Resistell at OBERON to see our Rapid AST solution at Pitch Night 2019, where 10 of Switzerland’s most promising young HealthTech startups will pitch their ideas alongside their counterparts from North America, including some of the Boston area’s favorite early Life Sciences startups.

We would like to thank the colleagues from the Uppsala Antibiotic Centre for the invitation to an excellent Symposium on Rapid ASTs. We are impressed by the quality of the event, participants and the discussions and honoured to be an invited speaker.